Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique
- PMID: 33436791
- PMCID: PMC7803958
- DOI: 10.1038/s41598-020-80017-6
Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique
Abstract
In 2005, the Nigerian Federal Ministry of Health revised the treatment policy for uncomplicated malaria with the introduction of artemisinin-based combination therapies (ACTs). This policy change discouraged the use of Sulphadoxine-pyrimethamine (SP) as the second-line treatment of uncomplicated falciparum malaria. However, SP is used as an intermittent preventive treatment of malaria in pregnancy (IPTp) and seasonal malaria chemoprevention (SMC) in children aged 3-59 months. There have been increasing reports of SP resistance especially in the non-pregnant population in Nigeria, thus, the need to continually monitor the efficacy of SP as IPTp and SMC by estimating polymorphisms in dihydropteroate synthetase (dhps) and dihydrofolate reductase (dhfr) genes associated with SP resistance. The high resolution-melting (HRM) assay was used to investigate polymorphisms in codons 51, 59, 108 and 164 of the dhfr gene and codons 437, 540, 581 and 613 of the dhps gene. DNA was extracted from 271 dried bloodspot filter paper samples obtained from children (< 5 years old) with uncomplicated malaria. The dhfr triple mutant I51R59N108, dhps double mutant G437G581 and quadruple dhfr I51R59N108 + dhps G437 mutant haplotypes were observed in 80.8%, 13.7% and 52.8% parasites, respectively. Although the quintuple dhfr I51R59N108 + dhps G437E540 and sextuple dhfr I51R59N108 + dhps G437E540G581 mutant haplotypes linked with in-vivo and in-vitro SP resistance were not detected, constant surveillance of these haplotypes should be done in the country to detect any change in prevalence.
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.Acta Trop. 2003 Mar;85(3):363-73. doi: 10.1016/s0001-706x(02)00264-4. Acta Trop. 2003. PMID: 12659974
-
Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.Acta Trop. 2005 Sep;95(3):183-93. doi: 10.1016/j.actatropica.2005.06.015. Acta Trop. 2005. PMID: 16023986
-
Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.Malar J. 2012 Jul 4;11:134. doi: 10.1186/1475-2875-11-134. Malar J. 2012. PMID: 22540158 Free PMC article.
-
Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations.Malar J. 2010 Aug 30;9:247. doi: 10.1186/1475-2875-9-247. Malar J. 2010. PMID: 20799995 Free PMC article.
-
Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso.Sci Rep. 2024 Oct 16;14(1):24224. doi: 10.1038/s41598-024-75369-2. Sci Rep. 2024. PMID: 39414909 Free PMC article.
Cited by
-
Sub-microscopic Plasmodium falciparum infections and multiple drug resistant single nucleotide polymorphic alleles in pregnant women from southwestern Nigeria.BMC Res Notes. 2024 May 9;17(1):129. doi: 10.1186/s13104-024-06763-2. BMC Res Notes. 2024. PMID: 38725016 Free PMC article.
-
Assessment of genetic polymorphisms associated with malaria antifolate resistance among the population of Libreville, Gabon.Malar J. 2023 Jun 14;22(1):183. doi: 10.1186/s12936-023-04615-1. Malar J. 2023. PMID: 37312220 Free PMC article.
-
Mapping Antimalarial Drug Resistance in Mozambique: A Systematic Review of Plasmodium falciparum Genetic Markers Post-ACT Implementation.Int J Mol Sci. 2024 Dec 20;25(24):13645. doi: 10.3390/ijms252413645. Int J Mol Sci. 2024. PMID: 39769406 Free PMC article.
-
Molecular Epidemiology of Drug Resistance Genes in Plasmodium falciparum Isolates Imported from Nigeria between 2016 and 2020: Continued Emergence of Fully Resistant Pfdhfr-Pfdhps Alleles.Microbiol Spectr. 2022 Oct 26;10(5):e0052822. doi: 10.1128/spectrum.00528-22. Epub 2022 Sep 15. Microbiol Spectr. 2022. PMID: 36106887 Free PMC article.
-
A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in Nigeria.Malar J. 2023 Mar 1;22(1):71. doi: 10.1186/s12936-023-04487-5. Malar J. 2023. PMID: 36859238 Free PMC article.
References
-
- Federal Ministry of Health . National Antimalarial Treatment Guidelines. Abuja: Federal Ministry of Health; 2005.
-
- WHO . World Malaria Report, 2013. Geneva: WHO; 2013.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources